Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
GCC-4002 by GC Cell for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
GCC-4002 is under clinical development by GC Cell and currently in Phase II for Adenocarcinoma Of The Gastroesophageal Junction. According...